spec

tech play

ISRG

Buy - Price 25.50 on Jan. 15
by Merriman Curhan Ford

Boston's Atrial Fibrillation Symposium, Jan. 17-19, isn't a top draw for investors, but is key...for Hansen's new Ensite-integrated Sensei...St. Jude's Ensite enables real-time mapping of any arrhythmia and navigating electrophysiology catheters. The system creates 3D displays of cardiac structures and arrhythmias, and enables catheter navigation without fluoroscopy. We believe [the mapping system]...has 40% market share...We expect FDA approval of Ensite-integrated Sensei system in 1Q08. Launch of the Ensite-integrated product...a label expansion and increased sales and manufacturing capacity provide multiple growth drivers for shares in '08. We remain bullish on the long-term potential of HNSN's open architecture. Market cap: $556 million.

opportunity to change industry

Wonderful prospects

Could be the next ISRG. Mindboggling surgery robotics equipment. Lots of Hedge Funds piling in. Nice entry at $25.00

Solid start by founders of ISRG. Cleveland Clinic likes ISRG and the robotic catheters made by HNSN. BUT a lot of form 144s recently (effect?)

robotic surgery; new patent; should grow like ISRG but slower according to conference call

This is one of only 2-3 medical robotic companies. As Cramer said the other night you need to have a business model like ISRG whereby you also sell the disposables as well as the robotics.

If ISRG is worth 360, per Cramer then I believe that HNSN is worth at least 50-75 within a year.